U.S Class(es): 006, 018, 044, 046, 051, 052
Name | Novartis Pharma AG, |
---|---|
Address | Trademark Department Postfach CH-4002 Basel SWITZERLAND |
Date | Description | Action Tags | Code |
---|---|---|---|
Jan-26-2024 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | INTRP | |
May-26-2023 | CANCELLED SECTION 71 | C71TO | |
Oct-27-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Apr-07-2017 | NOTIFICATION PROCESSED BY IB | GPNXP | |
Dec-15-2016 | FINAL DISPOSITION NOTICE SENT TO IB | FICSP | |
Dec-15-2016 | FINAL DISPOSITION PROCESSED | FIMPP | |
Dec-15-2016 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB | GPARP | |
Nov-15-2016 | REGISTERED-PRINCIPAL REGISTER | R.PRA | |
Aug-30-2016 | PUBLISHED FOR OPPOSITION | PUBOA | |
Aug-10-2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | OPNSP | |
Aug-10-2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | OP2RP | |
Aug-10-2016 | NOTICE OF PUBLICATION | NPUBO | |
Jul-28-2016 | APPROVED FOR PUB - PRINCIPAL REGISTER | CNSAO | |
Jul-22-2016 | ASSIGNED TO EXAMINER | DOCKD | |
Jul-16-2016 | APPLICATION FILING RECEIPT MAILED | MAFRO | |
Jul-12-2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | NWOSI | |
Jul-11-2016 | LIMITATION FROM ORIGINAL APPLICATION ENTERED | LIMII | |
Jul-07-2016 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB | SDRCM |